ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryBernInnoMedica Schweiz AG
InnoMedica Schweiz AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of InnoMedica is the development and production of nanotransport systems for the pharmaceutical industry, particularly for oncology, neurology and immunology. The company focuses on researching and developing nanocarriers that can release active ingredients in a targeted manner in the body, aiming to achieve improved efficacy with reduced side effects. Production takes place in its own GMP-certified nanofactory, which covers the entire value chain from raw material production to final product manufacturing.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

InnoMedica Schweiz AG

✓ Offered6
Liposomal Nanocarrier Platform
Liposomal nanocarriers for targeted drug delivery, with controlled release at the site of action, longer circulation in the bloodstream, and application for established and new drug classes.
Parkinson’s Therapy
Parkinson’s therapy with GM1 ganglioside in a nanocarrier, focused on overcoming the blood-brain barrier and clinical development up to Phase II.
Oncologic Therapy with Doxorubicin
Oncologic therapy with a liposomal doxorubicin formulation to reduce side effects and enable more targeted action, with clinical development in cancer indications.
GMP Production of Liposomal Medicines
GMP production of liposomal medicines in the Nanofactory, from raw material control to the sterile, injectable finished product.
CRDMO Services
CRDMO services for the development of liposomal medicines, including preclinical work, GMP production, clinical development, and regulatory support.
Development of Diagnostic Applications
Diagnostic applications using Talitrace and TLD-S, including intraoperative tumor marking and screening with a radio-tracer for PET imaging.
Trust & reputation

ranQ Trust Score of InnoMedica Schweiz AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

InnoMedica Schweiz AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
InnoMedica Schweiz AG scores 93.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
InnoMedica Schweiz AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
InnoMedica Schweiz AG scores 45.2 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.57.14%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.33.34%
Qualifications+0.00

InnoMedica Schweiz AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

March 31, 2025Media
Pharma-Startup angelt sich ehemaligen ZKB-Chef
finews.ch
May 17, 2021Media
Gibts doch noch eine Schweizer Covid-Impfung?
blick.ch
March 27, 2018Media
Ein trojanisches Pferd gegen den Krebstumor
derbund.ch

Knowledge

No knowledge articles yet

Once InnoMedica Schweiz AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

InnoMedica Schweiz AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank InnoMedica Schweiz AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of InnoMedica Schweiz AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Gesellschaftsstrasse 16
3012 Bern

At a glance

Legal form
Corporation
UID
CHE-106.033.889
Founded
1988 · 38 years
Last commercial register change
April 8, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.85.03%
    • Full methodology

    Similar companies

    AP
    Alpen Pharma AG
    Bern
    SP
    Space Pharmaceuticals AG
    Bern
    DG
    Dr. Gurtner Pharma AG
    Niederwangen B. Bern
    DE
    Dr. E. Gräub AG
    Bern
    MG
    msd GmbH
    Bern
    SP
    SPAGYRIK Produktions AG
    Burgdorf
    PS
    Phylak Sachsen (Schweiz) GmbH
    Lützelflüh-Goldbach
    BT
    BLEEDnFIRE Therapeutics AG
    Bern